TransMedics Group, Inc. (NASDAQ:TMDX – Get Rating) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 3,300,000 shares, a growth of 35.2% from the April 30th total of 2,440,000 shares. Based on an average daily volume of 635,600 shares, the […]
TransMedics Group (NASDAQ:TMDX – Get Rating) had its price objective lifted by stock analysts at Oppenheimer from $85.00 to $90.00 in a research report issued to clients and investors on Tuesday, The Fly reports. Oppenheimer’s target price would suggest a potential upside of 15.61% from the stock’s previous close. A number of other equities research […]